170 filings
10-Q
2024 Q1
BBIO
BridgeBio Pharma Inc
Quarterly report
2 May 24
4:24pm
8-K
BBIO
BridgeBio Pharma Inc
2 May 24
BridgeBio Pharma Reports First Quarter 2024 Financial Results and Business Update
7:31am
ARS
2023 FY
BBIO
BridgeBio Pharma Inc
25 Apr 24
Annual report to shareholders
4:07pm
DEFA14A
BBIO
BridgeBio Pharma Inc
25 Apr 24
Additional proxy soliciting materials
4:05pm
DEF 14A
BBIO
BridgeBio Pharma Inc
Definitive proxy
25 Apr 24
4:01pm
424B5
tjkp0 mtugz
6 Mar 24
Prospectus supplement for primary offering
5:15pm
8-K
kcr5flw
6 Mar 24
BridgeBio Pharma Announces Proposed Public Offering of Common Stock
5:13pm
424B5
lfkl njg4
4 Mar 24
Prospectus supplement for primary offering
5:25pm
8-K
4ut rd450w2lc
4 Mar 24
Entry into a Material Definitive Agreement
7:00am
8-K
y50w29ld9nq gxquda4
22 Feb 24
BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update
7:31am
8-K
bbrvnyll
18 Jan 24
Entry into a Material Definitive Agreement
7:30am
8-K
n7y5zhqmd89p4y 9l
8 Jan 24
Other Events
5:14pm
S-8
dcknaxc2i1 orepy0
5 Jan 24
Registration of securities for employees
4:06pm
S-3ASR
shkbnc r7
2 Nov 23
Automatic shelf registration
4:59pm
8-K
piydjw4c3gasq5oz49
2 Nov 23
BridgeBio Pharma Reports Third Quarter 2023 Financial Results and Business Update
7:31am
8-K
3du4cdwilgl
25 Sep 23
BridgeBio Pharma Announces $250 Million Private Placement Equity Financing
4:00pm
8-K
4lm6g
3 Aug 23
BridgeBio Pharma Reports Second Quarter 2023 Financial Results and Business Update
7:32am